Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on March 17, 2022. The report details a corporate governance action taken by the Board of Directors regarding the Company's Bylaws.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a change to corporate bylaws and does not contain financial performance data.
Material Changes
On March 17, 2022, the Board approved an amendment to the Amended and Restated Bylaws, effective immediately. The key change is a reduction in the quorum requirement for stockholder meetings:
- Previous Requirement: A majority of voting power.
- New Requirement: Holders of one-third (1/3) of the voting power of capital stock issued and outstanding.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the procedural amendment of the Bylaws.
Key Facts for Investor Verification
- Verify the effective date of the Bylaws Amendment (March 17, 2022).
- Confirm the new quorum threshold is set at one-third (1/3) of voting power.
- Review Exhibit 3.1 (First Amendment to the Amended and Restated Bylaws) for the full legal text of the change.